These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10578164)

  • 41. Case report of spontaneous remission of cytogenetic relapse of chronic myelogenous leukemia suggestive of progression to blast crisis after allogeneic bone marrow transplantation.
    Agaliotis DP; Papenhausen PR; Moscinski LC; Elfenbein GJ
    Ann Hematol; 1995 Jan; 70(1):37-41. PubMed ID: 7827205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recurrent isolated extramedullary relapses as granulocytic sarcomas following allogeneic bone marrow transplantation for acute myeloid leukemia.
    Au WY; Chan AC; Lie AK; Chen FE; Liang R; Kwong YL
    Bone Marrow Transplant; 1998 Jan; 21(2):205-8. PubMed ID: 9489639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Extramedullary (bone) relapse 16 months after allo bmt in a 7-year-old girl treated for acute lymphoblastic leukaemia from the second year of life].
    Tomaszewska R; Madziara W; Janik-Moszant A; Sonta-Jakimczyk D; Bohosiewicz J
    Med Wieku Rozwoj; 2001; 5(3 Suppl 1):37-42. PubMed ID: 12004150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple bone lesions after allogeneic bone marrow transplantation in a patient with relapsed adult acute lymphoblastic leukemia: minimal residual disease analysis may predict extramedullary relapse.
    Nomura K; Okamoto T; Nakao M; Ueda K; Akano Y; Fujita Y; Kobayashi M; Yokota S; Horiike S; Nishida K; Kusuzaki K; Taniwaki M
    Leuk Lymphoma; 2001; 42(6):1305-8. PubMed ID: 11911412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
    Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
    Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Donor lymphocyte infusion for childhood acute lymphoblastic leukaemia relapsing after bone marrow transplantation.
    Atra A; Millar B; Shepherd V; Shankar A; Wilson K; Treleaven J; Pritchard-Jones K; Meller ST; Pinkerton CR
    Br J Haematol; 1997 Apr; 97(1):165-8. PubMed ID: 9136960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The success of lymphocyte infusion as treatment of leukemia recurrence following allogeneic bone marrow transplantation depends on low percentage of patient's own lymphocytes].
    Schattenberg AV; van de Wiel-van Kemenade E; Bär BM; Geurts van Kessel AH; van der Maazen RW; de Witte TJ
    Ned Tijdschr Geneeskd; 1996 Oct; 140(42):2087-91. PubMed ID: 8965951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT).
    Frassoni F; Labopin M; Gluckman E; Prentice HG; Gahrton G; Mandelli F; Carella M; Herve P; Gratwohl A; Goldman J
    Leukemia; 1994 Jun; 8(6):924-8. PubMed ID: 8207985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extra-medullary relapse of leukemia following allogeneic bone marrow transplantation.
    Au WY; Kwong YL; Lie AK; Ma SK; Liang R
    Hematol Oncol; 1999 Jun; 17(2):45-52. PubMed ID: 10521868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
    Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
    Borgmann A; Hartmann R; Schmid H; Klingebiel T; Ebell W; Göbel U; Peters C; Gadner H; Henze G
    Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Donor lymphocyte infusion for the treatment of relapse after allogeneic hematopoietic stem cell transplantation.
    Helg C; Starobinski M; Jeannet M; Chapuis B
    Leuk Lymphoma; 1998 Apr; 29(3-4):301-13. PubMed ID: 9684928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term follow-up of leukaemia patients after related cryopreserved allogeneic bone marrow transplantation.
    Stockschläder M; Hassan HT; Krog C; Krüger W; Löliger C; Horstman M; Altnöder M; Clausen J; Grimm J; Kabisch H; Zander A
    Br J Haematol; 1997 Feb; 96(2):382-6. PubMed ID: 9029030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Matsue K; Tabayashi T; Yamada K; Takeuchi M
    Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S; Barnett L; Heller G
    Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of BCR/ABL RNA transcripts using the polymerase chain reaction is highly predictive for relapse in patients transplanted with unrelated marrow grafts for chronic myelogenous leukaemia.
    Drobyski WR; Endean DJ; Klein JP; Hessner MJ
    Br J Haematol; 1997 Aug; 98(2):458-66. PubMed ID: 9266951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission. Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) and the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Uderzo C; Valsecchi MG; Balduzzi A; Dini G; Miniero R; Locatelli F; Rondelli R; Pession A; Arcese W; Bacigalupo A; Polchi P; Andolina M; Messina C; Conter V; Aricó M; Galimberti S; Masera G
    Br J Haematol; 1997 Feb; 96(2):387-94. PubMed ID: 9029031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.